BioSpace News Archive

CPhI South East Asia – organised by Informa Markets – has been rescheduled for the newly confirmed date of 1-3 July, 2020 at the IMPACT Centre in Bangkok, Thailand.

Dr. Bopp is a pioneer in understanding the impact of the acidic tumour microenvironment on local immune cell function

Small cell lung cancer accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical outcomes.

The U.S. Food and Drug Administration issued a statement on Friday outlining what the agency is doing at home and abroad in response to the outbreak, which has infected more than 73,000 people worldwide.

In bone remains from a hadrosaur, researchers found lesions in tail vertebrae bones that are similar to the rare disease Langerhans cell histiocytosis, a type of cancer that begins in the bone marrow.

Although the concept of genome editing is just starting to gain traction, it has the potential to revolutionize health care by being able to treat, and in many cases cure, previously difficult-to-treat or untreatable genetic diseases. Intellia Therapeutics is focused on implementing a full-spectrum genome editing approach.

Evgen Pharma (Evgen) and The University of Rochester School of Medicine and Dentistry have entered into a Memorandum of Understanding to advance SFX-01 towards a clinical trial in chronic kidney disease (CKD).

New technique uses molecular ‘bait’ that is extremely specific and totally customizable to find and measure the amount of any molecule of interest, with wide-ranging applications in diagnostics and beyond

Agreement capitalizes on artificial intelligence and deep learning to develop therapeutic monoclonal antibodies, including novel bispecific antibodies (BiCKI® platform)

The trial’s goal is to test more than 700 patients infected with the coronavirus, but at this point, there have been fewer than 200 people recruited.